4//SEC Filing
Christiansen Andrew 4
Accession 0001666071-23-000097
CIK 0001666071other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:10 PM ET
Size
9.2 KB
Accession
0001666071-23-000097
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
Christiansen Andrew
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-07-18+30,147→ 84,179 total - Exercise/Conversion
Restricted Stock Units
2023-07-18+30,147→ 0 total→ Common Stock (30,147 underlying) - Sale
Common Stock
2023-07-19$10.20/sh−13,404$136,721→ 70,775 total
Footnotes (5)
- [F1]Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
- [F2]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on July 18, 2023
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.92 to $10.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
- [F4]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
- [F5]The RSUs shall vest in full on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.
Documents
Issuer
Cardlytics, Inc.
CIK 0001666071
Entity typeother
Related Parties
1- filerCIK 0001805400
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 4:10 PM ET
- Size
- 9.2 KB